{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-080180","form_type":"8-K","ticker":"OCUL","cik":"0001393434","company_name":"OCULAR THERAPEUTIX, INC","filed_at":"2023-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.772188+00:00","generated_at":"2026-06-13T09:20:58.292022+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Ocular Therapeutix elects Adrienne L. Graves, Ph.D. to board effective July 10, 2023","bullets":["Dr. Graves elected as Class I director, term until 2024 annual meeting.","Former President & CEO of Santen Inc. (US subsidiary of Japanese pharma).","Receives option to purchase 72,000 shares at $5.04/share and RSU for 24,000 shares.","Standard indemnification agreement entered upon election.","No material arrangements or transactions requiring disclosure under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-080180","json":"https://secwatch.observer/filing/0001104659-23-080180.json","markdown":"https://secwatch.observer/filing/0001104659-23-080180.md","text":"https://secwatch.observer/filing/0001104659-23-080180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393434/000110465923080180/0001104659-23-080180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393434/000110465923080180/tm2321078d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T09:20:58.292022+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"98e6059265","claim":"Adrienne L. Graves was elected as member of the Board at OCULAR THERAPEUTIX, INC.","evidence_excerpt":"On July 10, 2023 (the “Effective Date”), the board of directors (the “Board”) of Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Adrienne L. Graves, Ph.D., to serve as a member of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465923080180/0001104659-23-080180-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}